BRIEF REPORT The Uridine Diphosphate Glucuronosyltransferase 2B15 D 85 Y and 2B17 Deletion Polymorphisms Predict the Glucuronidation Pattern of Androgens and Fat Mass in Men
暂无分享,去创建一个
C. Swanson | C. Ohlsson | M. Lorentzon | L. Vandenput | M. Karlsson | F. Labrie | A. Rane | A. Eriksson | U. Smith | J. Jakobsson
[1] Claes Ohlsson,et al. Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] P. Bélanger,et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[3] O. Johnell,et al. Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] Claes Ohlsson,et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. , 2006, The Journal of clinical endocrinology and metabolism.
[5] D. Mellström,et al. Free Testosterone Is a Positive, Whereas Free Estradiol Is a Negative, Predictor of Cortical Bone Size in Young Swedish Men: The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] T. A. Bell,et al. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. , 2004, Genomics.
[7] O. Barbier,et al. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans , 2003, Trends in Endocrinology & Metabolism.
[8] E. Warren,et al. A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion , 2003, The Journal of experimental medicine.
[9] J. Simard,et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. , 2003, Endocrine reviews.
[10] D. Hum,et al. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. , 2001, Endocrinology.
[11] M. Green,et al. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. , 1997, Pharmacogenetics.
[12] I. Björkhem,et al. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases. , 1996, Journal of chromatography. B, Biomedical applications.
[13] D. Hum,et al. Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids* , 1996, The Journal of Biological Chemistry.
[14] B. Chung,et al. Analysis of anabolic steroids using GC/MS with selected ion monitoring. , 1990, Journal of analytical toxicology.
[15] F. Labrie,et al. Complete androgen blockade for the treatment of prostate cancer. , 1985, Important advances in oncology.